Ratan Tata invests in 18-year-old’s Generic Aadhaar to bring affordable medicines to masses
Arjun Deshpande started Generic Aadhaar in 2018 with an initial funding of Rs 15 lakhs from his parents, Ratan Tata has now made…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gilead scouting for partners in India, Pak for remdesivir
Recent clinical trial results and the decision by the US Food and Drug Administration (FDA) to issue ''Emergency Use…
Disappointed over negative reports about our products in India: Chinese suppliers of rapid test kits
In separate statements, Guongzhou Wondfo Biotech and Livzon Diagnostics said their products were being used by various countries…
Researchers launch race to develop sustainable COVID-19 vaccine delivery
Backed by the Shakti Sustainable Energy Foundation, experts from the University of Birmingham and Heriot-Watt University,…
DGFT issues clarification on export restrictions for alcohol sanitisers
Other products falling under the same ITC HS code are allowed to be exported
LANXESS robust in first quarter of 2020 despite coronavirus crisis
Sales down only slightly year-on-year at EUR 1.704 billion
LANXESS proved robust in the first quarter of the year – despite the…
USFDA extends review of Bristol Myers’ cancer therapy acquired in Celgene deal
The company said it had submitted additional information on the therapy known as liso-cel, which was considered a major amendment…
Open Science: Key to combat zoonosis
Largely opaque and proprietary R&D environments in the life sciences sector need to make way for strategies facilitated by…
SOTAX takes over software specialist SECOM GmbH
With this acquisition, SOTAX Group strengthens its portfolio in the data integrity-driven field of data management solutions for…
FDA approves first targetted therapy to treat aggressive form of lung cancer
The FDA also approved the FoundationOne CDx assay (F1CDx) as a companion diagnostic for Tabrecta
The US Food and Drug…